American Academy of Addiction Psychiatry (AAAP)

08/10/2026

Happening this Wednesday, August 12 — join us!

Join AAAP and presenter Ariela Vasserman, PsyD for the next Addiction Psychiatry Advanced Psychotherapy session, “CBT-I: The First-Line Treatment for Chronic Insomnia,” on Wednesday, August 12 from 4:00-5:30 PM ET.

This presentation will provide an overview of Cognitive Behavioral Therapy for Insomnia (CBT-I), the first-line, evidence-based treatment for chronic insomnia. Participants will review the empirical support for CBT-I, learn the core components of treatment, and gain practical guidance on assessment and implementation in clinical practice. The webinar will also examine the role of CBT-I in patients with co-occurring psychiatric conditions, with a particular focus on substance use disorders, highlighting its potential to improve sleep, support recovery, and reduce reliance on sleep medications.

Register: https://bit.ly/3Tx904i

08/07/2026

Take the course that 100% of past attendees recommend 🌟 Join us for the Advanced Addiction Psychopharmacology (AAP) Virtual Course on October 17-18, 2026!

This 14-hour online course is designed for physicians and other healthcare professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies.

Featuring nationally recognized faculty experts, this year’s course focuses on Treatment of Co-occurring Conditions, with content updated since the topic was last presented in 2024 to reflect current evidence and practice. New this year is a session on Pharmacotherapy of Insomnia with Co-Occurring Substance Use Disorders, addressing an area of growing clinical importance for prescribers managing patients with overlapping sleep and substance use disorders.

This two-day course features live webinar discussions and interactive Q&A sessions, designed for learners with a foundational understanding in addictions. Topics include:

🔹 Justine Welsh, MD: Pharmacotherapy of Substance Use Disorders in Adolescents
🔻 Constance Guille, MD: Pharmacotherapy: Perinatal Substance Use Disorders
🔹 Edward Nunes, MD: Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders
🔻 Frances Levin, MD: Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders
🔹 Christina Brezing, MD: Pharmacotherapy of Insomnia with Co-Occurring Substance Use Disorders - NEW!
🔻 Ismene Petrakis, MD: Pharmacotherapy of Post-Traumatic Stress Disorder with Co-Occurring Substance Use Disorders
🔹 John Mariani, MD: Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders
🔻 Kevin Sevarino, MD, PhD: Addiction Psychopharmacology of those with Co-Morbid Medical Conditions

Before the live sessions, learners will have access to on-demand lectures to review at their convenience. During the live component, participants will engage directly with expert presenters, who will address questions and expand on key topics covered in the lectures.

Don’t miss this opportunity to deepen your knowledge, connect with leading experts, and advance your expertise in Addiction Psychiatry and co-occurring disorders. Register by Friday, August 21 to lock in the early bird rate: https://bit.ly/3RFlQNk

08/06/2026

Join AAAP and presenter Ariela Vasserman, PsyD for the next Addiction Psychiatry Advanced Psychotherapy session, “CBT-I: The First-Line Treatment for Chronic Insomnia,” on Wednesday, August 12 from 4:00-5:30 PM ET.

This presentation will provide an overview of Cognitive Behavioral Therapy for Insomnia (CBT-I), the first-line, evidence-based treatment for chronic insomnia. Participants will review the empirical support for CBT-I, learn the core components of treatment, and gain practical guidance on assessment and implementation in clinical practice. The webinar will also examine the role of CBT-I in patients with co-occurring psychiatric conditions, with a particular focus on substance use disorders, highlighting its potential to improve sleep, support recovery, and reduce reliance on sleep medications.

Register: https://bit.ly/3Tx904i

08/03/2026

A new round of Pcss-Moud Exchange starts this Wednesday, August 5! 🩺

The PCSS-MOUD Exchange is a free four-session course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. It is intended for an interprofessional audience. Prescribers with frontline experience prescribing MOUD and developing clinic workflows will be available during all four sessions to answer participants’ questions and discuss real-world cases.

🗓️ Session 1 — Explore: Wednesday, August 5 at 3:00 PM ET
Facilitator: Sherry Larkins, PhD
Presenters: Laura Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN; Kristin Wason, NP-C, CARN; and Gavin Bart, MD, PhD, FACP, DFASAM

🗓️ Session 2 — Prepare: Wednesday, August 12 at 3:00 PM ET
Facilitator: Sherry Larkins, PhD
Presenters: Annie Potter, MSN, MPH, NP, CARN-AP; Gavin Bart, MD, PhD, FACP, DFASAM; and Kristin Wason, NP-C, CARN

🗓️ Session 3 — Implement/Sustain: Wednesday, August 19 at 3:00 PM ET
Facilitator: Sherry Larkins, PhD
Presenters: Nancy Regan MSN, FNP, CNM, CARN-AP; Hector Colon-Rivera, MD; and Candy Stockton, MD

🗓️ Session 4 — Implement/Sustain (Special Considerations): Wednesday, August 26 at 3:00 PM ET
Facilitator: Sherry Larkins, PhD
Presenters: Brian Fuehrlein, MD; Debbie Newman, PA-C, MPAS, MPH; and Candy Stockton, MD

Learn more and register: https://bit.ly/4xbmOzM

Have you already taken PCSS-MOUD Exchange? Tell your colleagues! 🗣️



Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

07/31/2026

Join Pcss-Moud and presenter Theddeus Iheanacho, MD for the clinical roundtable “Methadone- and Buprenorphine-Associated Drug-Drug Interactions” on Wednesday, August 5 from 1:30-2:30 PM ET.

When prescribing medication for opioid use disorder (MOUD), it is important to consider interactions with other drugs that may have adverse effects in patients. This roundtable is a follow-up to a recently presented PCSS-MOUD webinar. Dr. Iheanacho will summarize the main points of the webinar and then take questions from the audience. Come with a question you'd like answered!

At the conclusion of this activity, participants should be able to:
✅ Identify major clinically relevant drug-drug interactions between opioids and other medications
✅ Review possible explanations for drug-drug interactions
✅ Explain the physiological and pharmacokinetic mechanisms underlying adverse drug interactions
✅ Develop strategies for reducing risk of drug-drug interactions within the clinical setting

🩺 Target audience: Physicians, Physician Associates, Nurse and Nurse Practitioners, Pharmacists, and the Interprofessional team

⭐️ Credit designations available: AMA PRA Category 1 Credit™, AAPA Category 1 CME Credit, Nursing Contact Hour(s), Pharmacy Credit, IPCE Credit

Register: https://bit.ly/4xdOdkG

Funding for this initiative was made possible by grant no. 1H79TI088037 and cooperative agreement no. 1H79TI086770 from Substance Abuse Mental Health Services Administration (SAMHSA). The views expressed in these materials do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the United States Government.

Opioid Response Network

07/29/2026

Today, July 29, U.S. Department of Health and Human Services Secretary Robert F. Kennedy, Jr. convened with healthcare leaders, medical societies, providers, and behavioral health experts who pledged to enhance the nation’s behavioral health system.

The American Academy of Addiction Psychiatry (AAAP) was happy to be in attendance to sign the pledge, which commits to improving the quality of mental health and addiction care using evidence-based prevention, treatment, and recovery approaches. Together, we will continue to increase the standard of care and help more people achieve lasting recovery.

Read more from Politico: https://bit.ly/4yOeHuI

07/29/2026

📢 The 2025 is here! Explore trends in mental health, substance use, treatment and recovery in the U.S.—now with 5 years of comparable data: samhsa.gov/nsduh

07/27/2026

Annual Meeting Alert 🔔 Case conference submissions are due Tuesday, August 4!

📊 Primary goal: Promote lively and thoughtful discussion regarding the clinical management of patients with substance use disorders using a compelling case that touches on numerous relevant and current issues.
👤 Submitter: Trainees (fellows, residents, and medical students)
💡 Type: Didactic session
🗣️ Number of presenters: 1 plus discussants
✔️ Total number accepted: 1

Don’t miss the chance to make an impact in the field of Addiction Psychiatry this November 12-15 in Memphis, TN. Submit your abstract for the 37th Annual Meeting and Scientific Symposium today: https://bit.ly/40JTke5

07/23/2026

The American Academy of Addiction Psychiatry (AAAP) is proud to announce the publication of “AAAP Review of Addiction Psychiatry,” edited by Carla Marienfeld, MD, DFAPA, DFASAM, Chair of AAAP’s Continuing Professional Development Committee, and Maryam Soltani, MD, PhD.

Published by Springer Nature, “AAAP Review of Addiction Psychiatry” is an excellent resource for psychiatrists looking for a quick reference on addiction treatment and for all medical students, residents, fellows, and professionals taking certification exams in addiction, including those in psychiatry, addiction medicine, emergency medicine, internal medicine, pain medicine, and others. It includes 24 chapters, broken into four sections—Diagnosis, Treatment Modalities and Settings, and Recovery; Addictions and Their Treatment; Populations; and other topics, including public policy and legal considerations. Several AAAP members are listed as authors.

The book is available in formats including PDF for ebook download ($99) and hardcover ($129). Access here: https://bit.ly/4ftj6KD

To support your learning, AAAP is also developing a series of modules focused on each chapter. This learning opportunity will provide practical strategies for evaluating patient-specific risks and developing tailored treatment approaches through a variety of different modalities, including a free podcast, a case-based webinar, an expert panel discussion with leaders in the field, asynchronous case scenarios, a clinical round table, and 25 self-assessment questions to support practical application of key concepts. Stay tuned for more information!

07/21/2026

It's the American Academy of Addiction Psychiatry (AAAP)’s Virtual Advocacy Week!

New York AAAP Board Members (John J. Mariani, MD; Frances Levin, MD; Jose Vito, MD; and Philipa Owusu-Antwi, MD, MPH), along with Associate Executive Director Michelle Dirst and Advocacy Consultant Holly Strain, met with Senator Kirsten Gillibrand’s staff for a productive conversation.

We appreciate the Senator’s support on a range of important issues, from building community capacity to address opioid use disorders to addressing the rising rate of gambling addiction, and supporting efforts to recruit more Addiction Psychiatrists into the field.

Thank you to Senator Gillibrand's staff for taking the time to meet with us!